Professor David Price

Chair of Primary Care Respiratory Med

About

Email Address: d.price@abdn.ac.uk
Telephone Number: +44 (0)1224 437237
School/Department: School of Medicine, Medical Sciences and Nutrition

Publications

Page 14 of 86 Results 131 to 140 of 859

Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
2022 - Published
Price, D.
British Thoracic Society Winter Meeting 2022, pp. A54
Contributions to Conferences: Abstracts
- [ONLINE] https://www.brit-thoracic.org.uk/education-and-events/winter-meeting/
- [ONLINE] https://www.brit-thoracic.org.uk/media/456046/bts-winter-meeting-2022-final-programme-thorax-supplement.pdf
S88 Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
2022 - Published
Tse, G., Emmanuel, B., Ariti, C., Bafadhel, M., Papi, A., Carter, V., Zhou, J., Xu, X., Müllerová, H., Price, D., Skinner, D.
Thorax, vol. 77, no. Suppl. 1, pp. A54
Contributions to Journals: Abstracts
- [ONLINE] DOI: https://doi.org/10.1136/thorax-2022-BTSabstracts.94
- [ONLINE] https://www.brit-thoracic.org.uk/media/456046/bts-winter-meeting-2022-final-programme-thorax-supplement.pdf
P186 Facilitators to recruiting COPD patients to an adherence intervention trial
2022 - Published
Dickens, A., Halpin, D., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J., Mastoridis, P., Mezzi, K., Davis, S., Vijaykumar, E., Price, D.
Thorax, vol. 77, no. Suppl. 1, A182
Contributions to Journals: Abstracts
- [ONLINE] http://thorax.bmj.com/content/77/Suppl_1/A182.1.abstract
- [ONLINE] DOI: https://doi.org/10.1136/thorax-2022-BTSabstracts.320
Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial
2022 - Published
Dickens, A. P., Halpin, D. M., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F., Mastoridis, P., Mezzi, K., Davis, S., Vijaykumar, E., Price, D.
British Thoracic Society Winter Meeting 2022, pp. A72-A73
Contributions to Journals: Abstracts
- [ONLINE] http://thorax.bmj.com/content/77/Suppl_1/A72.abstract
- [ONLINE] DOI: https://doi.org/10.1136/thorax-2022-BTSabstracts.123
- [ONLINE] https://www.brit-thoracic.org.uk/education-and-events/winter-meeting/
Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma
2022 - Published
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
CHEST 2022, pp. A1909-A1913
Contributions to Journals: Abstracts
- [ONLINE] https://www.sciencedirect.com/science/article/pii/S0012369222029476
- [ONLINE] DOI: https://doi.org/10.1016/j.chest.2022.08.1587
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/24274/1/Gurnell_etal_CHEST_Dupilumab_Treatment_Leads_AAM.pdf
Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy
2022 - Published
Chen, W., Sadatsafavi, M., Tran, T. N., Murray, R. B., Wong, N. C. B., Ali, N., Ariti, C., Gil, E. G., Newell, A. P., Alacqua, M., Al-Ahmad, M., Altraja, H., Al-Lehebi, R., Bhutani, M., Bjermer, L., Bjerrum, A. S., Bourdin, A., Bulathsinhala, L., von Bülow, A., Busby, J., Canonica, G. W., Carter, V., Christoff, G., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Yoo, K. H., Heaney, L. G., Heffler, E., Hew, M., Hilberg, O., Hoyte, F., Iwanaga, T., Jackson, D. J., Jones, R. C., Siyue, M. K., Kuna, P., Larenas-Linnemann, D., Lehmann, S., Lehtimäki, L. A., Lyu, J., Mahboub, B., Maspero, J. F., Menzies-Gow, A., Sirena, C., Papadopoulos, N. G., Papaioannou, A. I., Perez de Llano, L., Perng, D. W., Peters, M., Pfeffer, P. E., Porsbjerg, C. M., Popov, T. A., Rhee, C. K., Salvi, S., Taillé, C., Taube, C., Torres-Duque, C. A., Suppli Ulrik, C., Ra, S. W., Eileen, W., Wechsler, M. E., Price, D.
Journal of Asthma and Allergy, vol. 15, no. 15, pp. 1491—1510
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.2147/JAA.S377174
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19342/2/Chen_etal_JAA_Characterization_Of_Patients_VoR.pdf
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
2022 - Published
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Deniz, Y., Siddiqui, S., Rowe, P.
AMCP Nexus 2022
Contributions to Conferences: Abstracts
Clinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study
2022 - Published
Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
CHEST 2022, pp. A28-A32
Contributions to Journals: Abstracts
- [ONLINE] https://www.sciencedirect.com/science/article/pii/S0012369222013800
- [ONLINE] DOI: https://doi.org/10.1016/j.chest.2022.08.020
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/21882/1/Ali_etal_CHEST_Clinical_Outcomes_In_AAM.pdf
Clinical Review: The suggested management pathway for urticaria in primary care
2022 - Published
Ryan, D., Tanno, L. K., Angier, L., Clark, E., Price, D., Zuberbier, T., Maurer, M.
Clinical and Translational Allergy, vol. 12, no. 10, e12195
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1002/clt2.12195
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19302/1/Ryan_etal_CTA_Clinical_Review_The_VoR.pdf
Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study
2022 - Published
Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
CHEST Annual Meeting, pp. A23-A27
Contributions to Journals: Abstracts
- [ONLINE] DOI: https://doi.org/10.1016/j.chest.2022.08.019
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/23031/1/Ali_etal_CHEST_Clinical_Outcomes_And_AAM.pdf

... 12
13
14
15
16 ...

Show 10 | 25 | 50 | 100 results per page

Update

Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study

S88 Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study

P186 Facilitators to recruiting COPD patients to an adherence intervention trial

Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial

Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma

Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy

Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

Clinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study

Clinical Review: The suggested management pathway for urticaria in primary care

Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Contributions to Specialist Publications

Working Papers

Other Contributions